Glimisung PM 2mg/500mg/15mg Tablet SR
Marketer
Neoliva Formulations
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimisung PM 2mg/500mg/15mg Tablet SR
Metformin/Glimepiride/Pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination therapy managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It improves insulin effectiveness, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed one and resume your regular schedule. Never double the dose; overdose risks hypoglycemia. Concurrent use with other antidiabetics, alcohol consumption, or skipped meals can increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Kidney function tests will be performed before treatment initiation. Limit alcohol intake, as it may heighten the risk of adverse effects.
Uses of Glimisung PM 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimisung PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimisung PM 2mg/500mg/15mg SR Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.
Common Side effects of Glimisung PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimisung PM 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimisung PM 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this extended-release tablet with a meal.
How Glimisung PM 2mg/500mg/15mg Tablet SR works:
Glimisung PM 2mg/500mg/15mg extended-release tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisung PM 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Glimisung PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against these risks before prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimisung PM 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available data from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Glimisung PM 2mg/500mg/15mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before administering. This medication is contraindicated in patients exhibiting severe renal insufficiency. Close monitoring of renal parameters is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimisung PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimisung PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimisung PM 2mg/500mg/15mg Tablet SR :
Should you forget a Glimisung PM 2mg/500mg/15mg Tablet SR dose, administer it immediately upon remembering. However, near the time for your next scheduled dose, omit the missed dose and resume your normal medication routine. Avoid taking a double dose.
Facts to Know About Glimisung PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently